Hesdorffer, DC, Ishihara, L, Mynepalli, L, Webb, DJ, Weil, J, Hauser, WA. Epilepsy, suicidality, and psychiatric disorders: a
bidirectional association. Ann Neurol
2012; 72: 184–91.
Hesdorffer, DC, Hauser, WA, Olafsson, E, Ludvigsson, P, Kjartansson, O. Depression and suicide attempt as risk factors for
incident unprovoked seizures. Ann Neurol
Cristancho, P, Cristancho, MA, Baltuch, GH, Thase, ME, O'Reardon, JP. Effectiveness and safety of vagus nerve stimulation
for severe treatment-resistant major depression in clinical practice
after FDA approval: outcomes at 1 year. J Clin
2011; 72: 1376–82.
Kosel, M, Brockmann, H, Frick, C, Zobel, A, Schlaepfer, TE. Chronic vagus nerve stimulation for
treatment-resistant depression increases regional cerebral blood flow in
the dorsolateral prefrontal cortex. Psychiatry
2011; 191: 153–9.
Lewy, AJ, Wehr, TA, Goodwin, FK, Newsome, DA, Markey, SP. Light suppresses melatonin secretion in
1980; 210: 1267–9.
Lam, RW, Levitt, AJ, Levitan, RD, Enns, MW, Morehouse, R, Michalak, EE, et al The Can-SAD study: a randomized controlled
trial of the effectiveness of light therapy and fluoxetine in patients
with winter seasonal affective disorder. Am J
2006; 163: 805–12.
Westrin, A, Lam, RW. Seasonal affective disorder: a clinical
update. Ann Clin Psychiatry
2007; 19: 239–46.
Golden, RN, Gaynes, BN, Ekstrom, RD, Hamer, RM, Jacobsen, FM, Suppes, T, et al The efficacy of light therapy in the treatment
of mood disorders: a review and meta-analysis of the
evidence. Am J Psychiatry
2005; 162: 656–62.
Tuunainen, A, Kripke, DF, Endo, T. Light treatment for non-seasonal
depression. Cochrane Database Syst Rev
Shirani, A, St Louis, EK. Illuminating rationale and uses for light
therapy. J Clin Sleep Med
2009; 5: 155–63.
Burns, A, Allen, H, Tomenson, B, Duignan, D, Byrne, J. Bright light therapy for agitation in dementia: a
randomized controlled trial. Int
2009; 21: 711–21.
Allen, NH, Kerr, D, Smythe, PJ, Martin, N, Osola, K, Thompson, C. Insulin sensitivity after phototherapy for seasonal
affective disorder. Lancet
1992; 339: 1065–6.
Baxendale, S, O'Sullivan, J, Heaney, D. Bright light therapy as an add on treatment for
medically intractable epilepsy. Epilepsy
2012; 24: 359–64.
Schulz, KF. CONSORT 2010 statement: updated guidelines for
reporting parallel group randomised trials.
Zigmond, AS, Snaith, RP. The Hospital Anxiety and Depression
Scale. Acta Psychiatr Scand
1983; 67: 361–70.
Terman, M, Terman, JS. Light therapy for seasonal and nonseasonal
depression: efficacy, protocol, safety, and side effects.
2005; 10: 647–63.
Lee, TM, Chan, CC. Dose-response relationship of phototherapy for
seasonal affective disorder: a meta-analysis.
Acta Psychiatr Scand
1999; 99: 315–23.
Wirz-Justice, A, Bucheli, C, Graw, P, Kielholz, P, Fisch, HU, Woggon, B. Light treatment of seasonal affective disorder in
Switzerland. Acta Psychiatr Scand
Berson, DM, Dunn, FA, Takao, M. Phototransduction by retinal ganglion cells that set
the circadian clock. Science
2002; 295: 1070–3.
Berson, DM. Strange vision: ganglion cells as circadian
photoreceptors. Trends Neurosci
2003; 26: 314–20.
Meesters, Y, Dekker, V, Schlangen, LJ, Bos, EH, Ruiter, MJ. Low-intensity blue-enriched white light (750 lux)
and standard bright light (10,000 lux) are equally effective in treating
SAD. A randomized controlled study. BMC
2011; 11: 17.